HEPATERA
Hepatera is a Russian biotechnology company founded in 2011. The main activity of the company is the search for and evaluation of promising drug candidates, as well as development and bringing to the Russian market safe and effective drugs for the treatment of liver diseases. First product (Myrcludex B) is aimed at the treatment of chronic hepatitis B and D. Myrcludex B is based on the research of the University Ruprecht-Karls-Universität Heidelberg, and is being developed in the framework of international cooperation with the biotechnology company MYR, GmbH (Germany). Since December 2011 Hepatera has become resident of Biomedical cluster of Skolkovo innovation center.
HEPATERA
Industry:
Biotechnology
Address:
Moscow, Moscow City, Russian Federation
Country:
Russian Federation
Website Url:
http://www.hepatera.ru
Status:
Active
Contact:
+7 (495) 726-52-53
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt IPv6 PHP Cloudflare PHP 7 Cloudflare Hosting
Similar Organizations
Official Site Inspections
http://www.hepatera.ru Semrush global rank: 5.34 M Semrush visits lastest month: 1.56 K
- Host name: server219.hosting.reg.ru
- IP address: 37.140.192.37
- Location: Russia
- Latitude: 55.7386
- Longitude: 37.6068
- Timezone: Europe/Moscow
More informations about "Hepatera"
Главная страница
более 550 пациентов в клинических исследованиях. Bogomolov P. et al. J Hepatol, 2016, 65: 490-8. Wedemeyer H. et. al. J Hepatol ...See details»
Hepatera - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number +7 (499) 968 62 77; Hepatera is a Russian biotechnology company founded in 2011. The main activity of the company is the search for …See details»
Контакты - hepatera.ru
Исследования осуществляются ООО «Гепатера» при грантовой поддержке Фонда «Сколково» ...See details»
Hepatera, LLC: Contact Details and Business Profile
"Hepatera", Ltd is a private biotechnology company, founded in 2011 with the goal to develop and launch into the Russian market innovative products for treatment of liver diseases. Since …See details»
Hepatera, LLC - LinkedIn
Hepatera, LLC | 91 followers on LinkedIn. "Hepatera", Ltd is a private biotechnology company, founded in 2011 with the goal to develop and launch into the Russian market innovative products for ...See details»
HEPATERA LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for HEPATERA LLC of Moscow, Moscow. Get the latest business insights from Dun & Bradstreet.See details»
Hepatera - Overview, News & Similar companies | ZoomInfo.com
Hepatera contact info: Phone number: +7 4957265253 Website: www.hepatera.ru What does Hepatera do? Hepatera Ltd is a private Russian biotech company funded by Maxwell Biotech …See details»
Hepatera 2025 Company Profile: Valuation, Funding & Investors
Hepatera General Information Description. Operator of a biotechnology company intended for the prevention and treatment of liver diseases. The company's innovative drug Myrcludex B is …See details»
Hepatera - 2025 Company Profile, Funding & Competitors - Tracxn
Feb 7, 2025 Hepatera is a funded company based in Moscow (Russia), founded in 2011. It operates as a Developing drug candidates for the treatment of viral disease of liver . The …See details»
Hepatera - Made in Russia
The Hepatera team is made up of exclusively highly qualified specialists. They are people who have more than one year of experience in clinical research and project management. These …See details»
Hepatera - monolith.madeinrussia.ru
Hepatera is a Russian biotechnology company whose main goal is to find and develop a cure for hepatitis B. Contact the representatives . Established in 2011, Hepatera is engaged in …See details»
Hepatera LLC - Drug pipelines, Patents, Clinical trials - Synapse
Explore Hepatera LLC with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, Drug:Bulevirtide Acetate.See details»
Hepatera, LLC Overview | SignalHire Company Profile
"Hepatera", Ltd is a private biotechnology company, founded in 2011 with the goal to develop and launch into the Russian market innovative products for treatment of liver diseases. ...See details»
Hepatera LLC (Hepatera LLC) - 药物管线_专利_临床试验_投融营收
了解Hepatera LLC (Hepatera LLC)公司的药物管线，治疗领域，技术平台，以及它的5项临床试验，药物:Bulevirtide Acetate。 产品. 数据. 资源. 版本对比. 预约演示. 免费注册. 更新于：2025 …See details»
Hepatera - VentureRadar
" Hepatera is a private biotechnology company, founded in 2011 with the goal to develop and launch into the Russian market innovative products for treatment of liver diseases. Show more …See details»
Клинические исследования - hepatera.ru
Цели лечения и критерии оценки в клинических исследованиях (Hepatitis Delta International Network – HDIN, 2019)See details»
Hepatera - Products, Competitors, Financials, Employees, …
About Hepatera. Hepatera is a biotechnology company focused on developing innovative treatments for liver diseases. The company's main product is a novel mechanism of action …See details»
Hepatera-Hepatera LLC-企业详情-InvestGO数据库-ByDrug-医药魔 …
查看医药魔方InvestGO®数据库Hepatera的公司信息。Hepatera（Hepatera LLC），公司简介：Hepatera is a Russian biotechnology company founded in 2011. The main activity of the …See details»
Публикации - hepatera.ru
Исследования осуществляются ООО «Гепатера» при грантовой поддержке Фонда «Сколково» ...See details»
Maxwell Biotech Venture Fund Invests in Hepatitis B/D Clinical …
Mar 21, 2012 Hepatera is a private Russian biotech company, that was founded in September 2011 and became a resident of the Biomedical Cluster at Skolkovo Innovation Center in …See details»